MONTANARI, Arianna
 Distribuzione geografica
Continente #
NA - Nord America 1.474
EU - Europa 474
AS - Asia 208
AF - Africa 21
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.195
Nazione #
US - Stati Uniti d'America 1.466
IT - Italia 208
SG - Singapore 85
IN - India 76
UA - Ucraina 73
SE - Svezia 64
FI - Finlandia 39
CN - Cina 36
BG - Bulgaria 22
GB - Regno Unito 22
TG - Togo 19
DE - Germania 15
AR - Argentina 14
BE - Belgio 10
CA - Canada 7
IE - Irlanda 7
KR - Corea 6
RO - Romania 5
MD - Moldavia 3
CL - Cile 2
NL - Olanda 2
PK - Pakistan 2
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
FR - Francia 1
JP - Giappone 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.195
Città #
Fairfield 249
Ashburn 140
Chandler 135
Rome 122
Woodbridge 93
Ann Arbor 92
Seattle 92
Cambridge 80
Houston 67
Wilmington 64
Princeton 40
Plano 38
Boston 32
Singapore 32
Beijing 28
San Paolo di Civitate 25
Jacksonville 23
Lawrence 22
Los Angeles 22
Sofia 22
Lomé 19
San Diego 17
Boardman 14
Federal 14
Millbury 11
Andover 10
Brussels 9
Washington 8
Des Moines 7
Milan 7
Dearborn 6
Dublin 6
New York 6
Norwalk 6
Mannheim 4
Mumbai 4
Phoenix 4
Santa Clara 4
Torino 4
Toronto 4
Bari 3
Bühl 3
Chisinau 3
Dallas 3
Ottawa 3
Bahawalpur 2
Bengaluru 2
Bremen 2
Buccinasco 2
Carrara 2
Civitavecchia 2
Clifton 2
Foligno 2
Frankfurt am Main 2
Fremont 2
Horia 2
Lappeenranta 2
London 2
Maple Grove 2
Moncalieri 2
Rozzano 2
Seongnam 2
Southend 2
Acerra 1
Acton 1
Affile 1
Ankara 1
Bastremoli 1
Delhi 1
Falkenstein 1
Falls Church 1
Finsbury Park 1
Fuzhou 1
Gent 1
Grafing 1
Hefei 1
Helsinki 1
Indianapolis 1
Jinan 1
Latina 1
Lima 1
Lisbon 1
Mahé 1
Modderfontein 1
Monterotondo 1
Nanjing 1
Napoli 1
Noicattaro 1
Oslo 1
Provo 1
Pune 1
Redmond 1
Rio Saliceto 1
San Mateo 1
Santiago 1
Santo Domingo Este 1
Seoul 1
Tallinn 1
The Hague 1
Tipperary 1
Totale 1.670
Nome #
Evaluation of the efficacy of carbon nanotubes for delivering peptides into mitochondria 96
Ubiquitin protease Ubp8 is necessary for S. cerevisiae respiration 96
The yeast model suggests the use of short peptides derived from mt LeuRS for the therapy of diseases due to mutations in several mt tRNAs 91
Biolistic Transformation for Delivering DNA into the Mitochondria 90
Can yeast be used to study mitochondrial diseases? Biolistic tRNA mutants for the analysis of mechanisms and suppressors 84
Unsaturated fatty acids-dependent linkage between respiration and fermentation revealed by deletion of hypoxic regulatory KlMGA2 gene in the facultative anaerobe-respiratory yeast Kluyveromyces lactis 84
Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations 81
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T > C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy 79
Functional roles of the fatty acid desaturases encoded by KLOLE1, FAD2 and FAD3 in the yeast Kluyveromyces lactis 72
Analyzing the suppression of respiratory defects in the yeast model of human mitochondrial tRNA diseases 71
Gcn5 histone acetyltransferase is present in the mitoplasts 70
SAGA complex and Gcn5 are necessary for respiration in budding yeast 68
The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells 66
Novel mutation in mitochondrial Elongation Factor EF-Tu associated to dysplastic leukoencephalopathy and defective mitochondrial DNA translation 65
Characterization of two tRNAleu mutants harbouring the equivalent pathogenic human substitutions T3250C and A3260G 62
Mitochondrial diseases: Yeast as a model for the study of suppressors 61
Structural and functional role of bases 32 and 33 in the anticodon loop of yeast mitochondrial tRNAIle 59
A novel mutation in NDUFB11 unveils a new clinical phenotype associated with lactic acidosis and sideroblastic anemia 58
Aminoacyl-tRNA synthetases are multivalent suppressors of defects due to human equivalent mutations in yeast mt tRNA genes 56
Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations 54
Yeast as a model of human mitochondrial tRNA base substitutions: Investigation of the molecular basis of respiratory defects 54
Mutations in yeast mt tRNAs: specific and general suppression by nuclear encoded tRNA interactors 49
Light-stress response mediated by the transcription factor KlMga2 in the yeast Kluyveromyces lactis 49
Nuclearly encoded mitochondrial protein synthesis factors can “cure” the respiratory defects due to pathogenetic human equivalent base substitutions in yeast mt tRNA genes 46
Yeast respiratory defects caused by pathogenetic human equivalent base substitutions in mt tRNA genes can be rescued by overexpression of aminoacyl-tRNA synthetases 45
Peptides from aminoacyl-tRNA synthetases can cure the defects due to mutations in mt tRNA genes 45
Yeast biolistic tRNA mutants equivalent to pathogenic human mitochondrial mutations: a model for the study of mechanisms and suppressors 41
Light stress in yeasts: signaling and responses in creatures of the night 40
Mitochondrial DNA disorders: analysis of tRNA mutations in S. cerevisiae 38
The contribution of yeast to understand mitochondrial diseases 37
In vitro probiotic properties and in vivo anti-ageing effects of Lactoplantibacillus plantarum PFA2018AU strain isolated from carrots on Caenorhabditis elegans 36
Molecole peptidiche per il trattamento di patologie mitocondriali 36
tRNA interactors as suppressors of mitochondrial defects due to pathogenetic human equivalent base substitutions in yeast mt tRNA genes 34
Peptide molecules for treating mitochondrial pathologies 33
Mitochondrial tRNA base substitutions: investigation of the molecular basis of respiratory defects 31
Mitochondrial tRNA pathogenetic human substitutions: analysis of the yeast equivalent mutants and study of suppressive effect of interactor molecules. 30
Yeast as a tool for in vivo study of human mitochondrial tRNA mutations 28
Un modello cellulare per le malattie mitocondriali 25
Strain-specific nuclear genetic background differentially affects mitochondria-related phenotypes in Saccharomyces cerevisiae 23
Silencing of the mitochondrial ribosomal protein L-24 gene activates the oxidative stress response in Caenorhabditis elegans 23
YEAST AS MODELS FOR MITOCHONDRIAL DISEASES 21
Bioinformatics and experimental characterization of yeast mitochondrial tRNA mutantsresponsible for defective phenotypes mirroring human pathologies 21
Role of yUbp8 in Mitochondria and Hypoxia Entangles the Finding of Human Ortholog Usp22 in the Glioblastoma Pseudo-Palisade Microlayer 19
In vivo analysis of mitochondrial protein synthesis in Saccharomyces cerevisiae mitochondrial tRNA mutants 16
A novel homozygous variant in COX5A causes an attenuated phenotype with failure to thrive, lactic acidosis, hypoglycemia, and short stature 6
Totale 2.289
Categoria #
all - tutte 6.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 189
selected - selezionate 0
volume - volumi 0
Totale 6.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020373 0 0 6 24 48 47 54 56 53 39 30 16
2020/2021183 30 29 4 9 7 17 1 17 22 25 18 4
2021/2022408 0 30 44 14 51 9 14 38 35 28 58 87
2022/2023453 68 91 19 39 62 42 4 31 35 17 24 21
2023/2024302 13 34 16 29 48 47 3 10 11 45 26 20
2024/202559 27 9 23 0 0 0 0 0 0 0 0 0
Totale 2.289